世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

感染性呼吸器疾患診断の市場規模、シェア&動向分析:製品タイプ別(機器、サービス)、サンプルタイプ別(血液、NPS)、アプリケーション別、技術別、セグメント予測、2022年~2030年


Infectious Respiratory Disease Diagnostics Market Size, Share & Trends Analysis By Product Type (Instruments, Services), By Sample Type (Blood, NPS), By Application, By Technology, And Segment Forecasts, 2022 - 2030

感染性呼吸器疾患診断薬市場の成長とトレンド グランドビューリサーチ社の最新レポートによると、感染性呼吸器疾患診断の世界市場規模は、2030年までに436億米ドルに達し、予測期間中に-1.8%のCAGRを記録する... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2022年9月8日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
162 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

感染性呼吸器疾患診断薬市場の成長とトレンド

グランドビューリサーチ社の最新レポートによると、感染性呼吸器疾患診断の世界市場規模は、2030年までに436億米ドルに達し、予測期間中に-1.8%のCAGRを記録すると予測されています。市場規模の減少は、主にCOVID-19検査の減少に起因しています。しかし、COVID-19の影響を受けない市場は、予測期間中に成長すると予想されます。この成長は、感染性呼吸器疾患の有病率の増加、および需要の増加に対応するために政府および非営利団体が新規および革新的な製品を導入するために行っているイニシアチブに起因していると考えられます。例えば、結核研究開発への世界的な投資は9億1500万米ドルに達し、2020年には米国政府によって約4億100万米ドルが結核の研究に費やされました。

予測期間中、世界の産業は、結核、RSV、インフルエンザなどの感染性呼吸器疾患の発生率の上昇によって牽引されると予想されます。国連によると、肺炎は毎年約420万人が罹患しています。主要企業は、感染症診断のための診断薬や消耗品の需要増に対応するため、生産性を向上させる革新的な技術の開発に取り組んでいます。例えば、オプトインダストリー社は、COVID-19の大流行によるサンプル採取キットの供給不足に対処するため、3Dプリントシステムを活用したInstaSwabを発表しました。この綿棒は、格子を編んで作られており、従来の綿棒よりも多くの液体を吸収・放出することができます。企業は、ターゲットに特化した正確な結果を得るために新しい技術を使用することで、診断製品を進化させています。

キヤノン株式会社は、2021年3月にデジタルX線用の内蔵型AECアシストを開発したと発表した。X線イメージセンサーにより、放出されたX線に対応する画像生成とリアルタイム検出を行うことができる。さらに、2021年5月には、チップ技術を利用してSARS-CoV-2やインフルエンザA抗原の有無を識別する超高感度分子検査法を開発した。また、RSV、インフルエンザ、COVID-19の呼吸器疾患を同時に診断するためのマルチプレックス検査も各社から発売されています。RT-PCR検査は、患者のCOVID-19の診断のためのゴールドスタンダードと考えられています。しかし、分子検査に関連する高価格は、この市場を阻害する主な要因の1つです。

類似製品の不足も価格高騰の原因となっています。この問題は、各分子診断製品の用途によって価格が大きく異なることで、さらに深刻化しています。企業は、感染性呼吸器疾患診断製品の浸透を高めるために、新製品の上市や提携などの戦略を採用しています。例えば、2021年8月、サーモフィッシャーサイエンティフィック社は、TaqPath COVID-19 RNase P Combo KitとTaqPath COVID-19 Fast PCR Combo Kitという2つのCOVID-19診断製品の米国市場への導入についてEUAを受けています。

感染性呼吸器疾患診断薬市場レポートハイライト

- 2021年には、COVID-19診断のための高い検査率と近年の複数のアッセイの製品化により、消耗品セグメントが最大の収益シェアを占め、予測期間中もその優位性を維持すると予想される

- COVID-19診断におけるPCR技術の利用が増加していることから、2021年には分子診断薬が最も高い売上シェアを占めた

- COVID-19診断における高い使用率により、鼻咽頭スワブサンプルタイプのセグメントが2021年に最も高い売上高シェアを占めた

- COVID-19用途分野は、高い発症率、製品承認の増加、革新的な製品を発売するための高い研究開発イニシアチブなどの要因により、2021年の業界をリードしている

- 結核は、診断薬の開発に対する政府の注力と研究開発資金の増加により、予測期間において最も速いCAGRを示すと予想される

- IVD製品の普及率の上昇、可処分所得の増加、低開発国における結核の高い有病率により、予測期間中、アジア太平洋地域が最も速い成長を遂げると予測される



ページTOPに戻る


目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Infectious Respiratory Disease Diagnostics Market Variables, Trends, and Scope
3.1 Penetration and Growth Prospect Mapping
3.2 Market Driver analysis
3.2.1 High Prevalence Of Infectious Respiratory Diseases Globally
3.2.2 Technological Advancement In Respiratory Disease Testing
3.2.3 Rising R&D Investments In Respiratory Disease Testing
3.3 Market Restraint Analysis
3.3.1 High Prices Of Diagnostic Products
3.3.2 Presence Of Ambiguous Regulatory Framework
3.4 Market Opportunity Analysis
3.4.1 Increasing Adoption Of Self-Testing Products And Point-Of-Care Products
3.4.2 Increasing Focus On Introducing Multiplex Pcr
3.5 Covid Impact Analysis
3.6 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
3.7 Industry Analysis - Porter’s
3.8 Multiplex testing in infectious respiratory disease testing, market opportunity
Chapter 4 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Product Type, 2018 - 2030 (USD Million)
4.1 Definitions and Scope
4.2 Infectious Respiratory Disease Diagnostics Market: Product Type Movement Analysis
4.3 Instruments
4.3.1 Instruments Market, 2018 - 2030 (USD Million)
4.3.2 Imaging Tests
4.3.2.1 Imaging Tests Market, 2018 - 2030 (USD Million)
4.3.3 Respiratory Measurement Devices
4.3.3.1 Respiratory Measurement Devices Market, 2018 - 2030 (USD Million)
4.3.4 Other Instruments
4.3.4.1 Other Instruments Market, 2018 - 2030 (USD Million)
4.4 Consumables
4.4.1 Consumables Market, 2018 - 2030 (USD Million)
4.5 Services
4.5.1 Services Market, 2018 - 2030 (USD Million)
Chapter 5 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Sample Type, 2018 - 2030 (USD Million)
5.1 Definitions & Scope
5.2 Infectious Respiratory Disease Diagnostics Market: Sample Type Movement Analysis
5.3 Saliva
5.3.1 Saliva Market, 2018 - 2030 (USD Million)
5.4 Nasopharyngeal Swabs (Nps)
5.4.1 Nasopharyngeal Swabs (Nps) Market, 2018 - 2030 (USD Million)
5.5 Anterior Nasal Region
5.5.1 Anterior Nasal Region Market, 2018 - 2030 (USD Million)
5.6 Blood
5.6.1 Blood Market, 2018 - 2030 (USD Million)
5.7 Others
5.7.1 Others Market, 2018 - 2030 (USD Million)
Chapter 6 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Technology, 2018 - 2030 (USD Million)
6.1 Definitions and Scope
6.2 Infectious Respiratory Disease Diagnostics Market: Technology Movement Analysis
6.3 Immunoassay
6.3.1 Immunoassay Market, 2018 - 2030 (USD Million)
6.4 Molecular Diagnostics
6.4.1 Molecular Diagnostics Market, 2018 - 2030 (USD Million)
6.5 Microbiology
6.5.1 Microbiology Market, 2018 - 2030 (USD Million)
6.6 Other Technologies
6.6.1 Other Technologies Market, 2018 - 2030 (USD Million)
Chapter 7 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Application, 2018 - 2030 (USD Million) (‘000)
7.1 Infectious Respiratory Disease Diagnostics Market: Application Movement Analysis
7.2 COVID-19
7.2.1 Covid-19 Market, 2018 - 2030 (USD Million)
7.2.2 Covid-19 Market, 2018 - 2030 (Volume ‘000)
7.3 Influenza
7.3.1 Influenza Market, 2018 - 2030 (USD Million)
7.3.2 Influenza Market, 2018 - 2030 (Volume ‘000)
7.4 Respiratory Syncytial Virus
7.4.1 Respiratory Syncytial Virus Market, 2018 - 2030 (USD Million)
7.4.2 Respiratory Syncytial Virus Market, 2018 - 2030 (Volume ‘000)
7.5 Tuberculosis
7.5.1 Tuberculosis Market, 2018 - 2030 (USD Million)
7.5.2 Tuberculosis Market, 2018 - 2030 (Volume ‘000)
7.6 Streptococcus Testing
7.6.1 Streptococcus Testing Market, 2018 - 2030 (USD Million)
7.6.2 Streptococcus Testing Market, 2018 - 2030 (Volume ‘000)
7.7 Other Respiratory Disease Testing
7.7.1 Other Respiratory Disease Testing Market, 2018 - 2030 (USD Million)
7.7.2 Other Respiratory Disease Testing Market, 2018 - 2030 (Volume ‘000)
Chapter 8 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by End-use, 2018 - 2030 (USD Million)
8.1 Infectious Respiratory Disease Diagnostics Market: End-use Movement Analysis
8.2 Hospitals
8.2.1 Hospitals Market, 2018 - 2030 (USD Million)
8.3 Diagnostic Laboratories
8.3.1 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
8.4 Physician Offices
8.4.1 Physician Offices Market, 2018 - 2030 (USD Million)
8.5 Other End-Users
8.5.1 Other End-Users Market, 2018 - 2030 (USD Million)
Chapter 9 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)
9.1 Market Share Analysis
9.2 Regional Market Share Analysis, 2021 & 2030
9.3 Regional Market Snapshot
9.4 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
9.4.1 North America
9.4.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
9.4.1.2 U.S.
9.4.1.2.1 U.S. Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.1.3 Canada
9.4.1.3.1 Canada Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2 Europe
9.4.2.1 Europe Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.2 U.K.
9.4.2.2.1 U.K. Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.3 Germany
9.4.2.3.1 Germany Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.4 Spain
9.4.2.4.1 Spain Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.5 France
9.4.2.5.1 France Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.6 Italy
9.4.2.6.1 Italy Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.7 Russia
9.4.2.7.1 Russia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3 Asia Pacific
9.4.3.1 Asia Pacific Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.2 Japan
9.4.3.2.1 Japan Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.3 China
9.4.3.3.1 China Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.4 India
9.4.3.4.1 India Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.5 South Korea
9.4.3.5.1 South Korea Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.6 Australia
9.4.3.6.1 Australia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.7 Singapore
9.4.3.7.1 Singapore Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.4 Latin America
9.4.4.1 Latin America Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.4.2 Brazil
9.4.4.2.1 Brazil Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.4.3 Mexico
9.4.4.3.1 Mexico Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.4.4 Argentina
9.4.4.4.1 Argentina Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.5 MEA
9.4.5.1 MEA Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.5.2 South Africa
9.4.5.2.1 South Africa Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.5.3 Saudi Arabia
9.4.5.3.1 Saudi Arabia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.5.4 UAE
9.4.5.4.1 UAE Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
Chapter 10 Infectious Respiratory Disease Diagnostics Market: Competitive Analysis
10.1 Recent Developments and Impact Analysis, by Key Market Participants
10.1.1 New Product Launches
10.1.2 Mergers And Acquisitions
10.1.3 Partnerships And Strategic Collaboration
10.1.4 Conferences And Campaigns
10.2 Company Categorization
10.2.1 Innovators
10.2.2 Market Leaders
10.2.3 Heat Map Analysis
10.3 Vendor Landscape
10.3.1 List Of Key Distributors And Channel Partners
10.3.2 Key Customers
10.4 Key Company Market Share Analysis, 2021
10.5 Public Companies
10.5.1 Company Market Position Analysis
10.5.2 Company Market Position Analysis
10.5.3 Competitive Dashboard Analysis
10.5.3.1 Market Differentiators
10.6 Private Companies
10.6.1 List Of Key Emerging Companies
10.6.2 Regional Network Map
10.7 Company Profiles
10.7.1 ABBOTT
10.7.1.1 Company overview
10.7.1.2 Financial performance
10.7.1.3 Product benchmarking
10.7.1.4 Strategic initiatives
10.7.2 THERMO FISHER SCIENTIFIC, INC.
10.7.2.1 Company overview
10.7.2.2 Financial performance
10.7.2.3 Product benchmarking
10.7.2.4 Strategic initiatives
10.7.3 KONINKLIJKE PHILIPS N.V.
10.7.3.1 Company overview
10.7.3.2 Financial performance
10.7.3.3 Product benchmarking
10.7.3.4 Strategic initiatives
10.7.4 F. HOFFMANN-LA ROCHE LTD
10.7.4.1 Company overview
10.7.4.2 Financial performance
10.7.4.3 Product benchmarking
10.7.4.4 Strategic initiatives
10.7.5 BIOMÉRIEUX SA
10.7.5.1 Company overview
10.7.5.2 Financial performance
10.7.5.3 Product benchmarking
10.7.5.4 Strategic initiatives
10.7.6 BIO-RAD LABORATORIES, INC.
10.7.6.1 Company overview
10.7.6.2 Financial performance
10.7.6.3 Product benchmarking
10.7.6.4 Strategic initiatives
10.7.7 QUIDEL CORPORATION
10.7.7.1 Company overview
10.7.7.2 Financial performance
10.7.7.3 Product benchmarking
10.7.7.4 Strategic initiatives
10.7.8 CEPHEID (DANAHER)
10.7.8.1 Company Overview
10.7.8.2 Financial Performance
10.7.8.3 Product Benchmarking
10.7.8.4 Strategic Initiatives
10.7.9 QIAGEN
10.7.9.1 Company Overview
10.7.9.2 Financial Performance
10.7.9.3 Product Benchmarking
10.7.9.4 Strategic Initiatives
10.7.10 SIEMENS HEALTHCARE GMBH
10.7.10.1 Company Overview
10.7.10.2 Financial Performance
10.7.10.3 Product Benchmarking
10.7.10.4 Strategic Initiatives

 

ページTOPに戻る


 

Summary

Infectious Respiratory Disease Diagnostics Market Growth & Trends

The global infectious respiratory disease diagnostics market size is expected to reach USD 43.6 billion by 2030, registering a CAGR of -1.8% over the forecast period, according to a new report by Grand View Research, Inc. The decline in market size is majorly attributed to the decline in COVID-19 testing. However, the market without the impact of COVID-19 is expected to grow over the forecast years. The growth can be attributed to an increase in the prevalence of infectious respiratory diseases and initiatives taken by governments & nonprofit organizations to introduce novel & innovative products to address the increasing demand. For instance, the global investment in tuberculosis R&D reached USD 915 million, and around USD 401 million was spent by the U.S. government on TB research in 2020.

During the forecast period, the global industry is expected to be driven by the rising incidence of infectious respiratory disorders, such as tuberculosis, RSV, and influenza. According to the UN, pneumonia affects around 4.2 million people every year. Key players are developing innovative techniques to improve production for meeting the growing demand in diagnostics and consumables for the diagnosis of infectious diseases. For instance, OPT Industries Inc. has introduced InstaSwab by utilizing the 3D printing system to address supply shortages of sample collection kits due to the COVID-19 pandemic. These swabs are made of woven lattices to absorb and release more fluid than conventional swabs. Companies are advancing their diagnosis products by using new techniques to gain target-specific and accurate results.

Canon Inc. announced the development of a built-in AEC assistance for digital X-rays in March 2021. The X-ray image sensor enables users to perform picture production and real-time detection of images corresponding to emitted X-rays. Furthermore, in May 2021, the University of California developed an ultrasensitive molecular test to identify the presence of SARS-CoV-2 and influenza A antigens using chip technology. In addition, companies are also launching multiplex tests for the simultaneous diagnosis of RSV, influenza, and COVID-19 respiratory diseases. RT-PCR tests are considered the gold standard for the diagnosis of COVID-19 in patients. However, high prices associated with molecular tests are one of the major factors impeding this market.

The lack of comparable products is another reason for hiked prices. This problem is further compounded by the significant variations in prices for different applications of each molecular diagnostic product. Companies are adopting strategies, such as new product launches and partnerships, to increase the penetration of infectious respiratory disease diagnostics products. For instance, in August 2021, Thermo Fisher Scientific Inc. received EUA for the introduction of two COVID-19 diagnostic products, TaqPath COVID-19 RNase P Combo Kit and TaqPath COVID-19 Fast PCR Combo Kit, in the U.S. market.

Infectious Respiratory Disease Diagnostics Market Report Highlights

• In 2021, the consumables segment accounted for the largest revenue share and is anticipated to maintain its dominance over the forecast period owing to high testing rates for the diagnosis of COVID-19 and the commercialization of multiple assays in recent years

• Molecular diagnostics accounted for the highest revenue share in 2021, owing to the increasing use of PCR technology for COVID-19 diagnosis

• The nasopharyngeal swabs sample type segment accounted for the highest revenue share in 2021 owing to high usage in COVID-19 diagnosis

• The COVID-19 application segment led the industry in 2021 due to factors, such as high incidence rate, increasing product approvals, and high R&D initiatives for launching innovative products

• Tuberculosis is expected to exhibit the fastest CAGR over the forecast period owing to increasing government focus and R&D funding for the development of diagnostics

• Asia Pacific is expected to experience the fastest growth over the forecast period owing to an increase in penetration of IVD products, rise in disposable income, and high prevalence of tuberculosis in underdeveloped countries



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Infectious Respiratory Disease Diagnostics Market Variables, Trends, and Scope
3.1 Penetration and Growth Prospect Mapping
3.2 Market Driver analysis
3.2.1 High Prevalence Of Infectious Respiratory Diseases Globally
3.2.2 Technological Advancement In Respiratory Disease Testing
3.2.3 Rising R&D Investments In Respiratory Disease Testing
3.3 Market Restraint Analysis
3.3.1 High Prices Of Diagnostic Products
3.3.2 Presence Of Ambiguous Regulatory Framework
3.4 Market Opportunity Analysis
3.4.1 Increasing Adoption Of Self-Testing Products And Point-Of-Care Products
3.4.2 Increasing Focus On Introducing Multiplex Pcr
3.5 Covid Impact Analysis
3.6 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
3.7 Industry Analysis - Porter’s
3.8 Multiplex testing in infectious respiratory disease testing, market opportunity
Chapter 4 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Product Type, 2018 - 2030 (USD Million)
4.1 Definitions and Scope
4.2 Infectious Respiratory Disease Diagnostics Market: Product Type Movement Analysis
4.3 Instruments
4.3.1 Instruments Market, 2018 - 2030 (USD Million)
4.3.2 Imaging Tests
4.3.2.1 Imaging Tests Market, 2018 - 2030 (USD Million)
4.3.3 Respiratory Measurement Devices
4.3.3.1 Respiratory Measurement Devices Market, 2018 - 2030 (USD Million)
4.3.4 Other Instruments
4.3.4.1 Other Instruments Market, 2018 - 2030 (USD Million)
4.4 Consumables
4.4.1 Consumables Market, 2018 - 2030 (USD Million)
4.5 Services
4.5.1 Services Market, 2018 - 2030 (USD Million)
Chapter 5 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Sample Type, 2018 - 2030 (USD Million)
5.1 Definitions & Scope
5.2 Infectious Respiratory Disease Diagnostics Market: Sample Type Movement Analysis
5.3 Saliva
5.3.1 Saliva Market, 2018 - 2030 (USD Million)
5.4 Nasopharyngeal Swabs (Nps)
5.4.1 Nasopharyngeal Swabs (Nps) Market, 2018 - 2030 (USD Million)
5.5 Anterior Nasal Region
5.5.1 Anterior Nasal Region Market, 2018 - 2030 (USD Million)
5.6 Blood
5.6.1 Blood Market, 2018 - 2030 (USD Million)
5.7 Others
5.7.1 Others Market, 2018 - 2030 (USD Million)
Chapter 6 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Technology, 2018 - 2030 (USD Million)
6.1 Definitions and Scope
6.2 Infectious Respiratory Disease Diagnostics Market: Technology Movement Analysis
6.3 Immunoassay
6.3.1 Immunoassay Market, 2018 - 2030 (USD Million)
6.4 Molecular Diagnostics
6.4.1 Molecular Diagnostics Market, 2018 - 2030 (USD Million)
6.5 Microbiology
6.5.1 Microbiology Market, 2018 - 2030 (USD Million)
6.6 Other Technologies
6.6.1 Other Technologies Market, 2018 - 2030 (USD Million)
Chapter 7 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by Application, 2018 - 2030 (USD Million) (‘000)
7.1 Infectious Respiratory Disease Diagnostics Market: Application Movement Analysis
7.2 COVID-19
7.2.1 Covid-19 Market, 2018 - 2030 (USD Million)
7.2.2 Covid-19 Market, 2018 - 2030 (Volume ‘000)
7.3 Influenza
7.3.1 Influenza Market, 2018 - 2030 (USD Million)
7.3.2 Influenza Market, 2018 - 2030 (Volume ‘000)
7.4 Respiratory Syncytial Virus
7.4.1 Respiratory Syncytial Virus Market, 2018 - 2030 (USD Million)
7.4.2 Respiratory Syncytial Virus Market, 2018 - 2030 (Volume ‘000)
7.5 Tuberculosis
7.5.1 Tuberculosis Market, 2018 - 2030 (USD Million)
7.5.2 Tuberculosis Market, 2018 - 2030 (Volume ‘000)
7.6 Streptococcus Testing
7.6.1 Streptococcus Testing Market, 2018 - 2030 (USD Million)
7.6.2 Streptococcus Testing Market, 2018 - 2030 (Volume ‘000)
7.7 Other Respiratory Disease Testing
7.7.1 Other Respiratory Disease Testing Market, 2018 - 2030 (USD Million)
7.7.2 Other Respiratory Disease Testing Market, 2018 - 2030 (Volume ‘000)
Chapter 8 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, by End-use, 2018 - 2030 (USD Million)
8.1 Infectious Respiratory Disease Diagnostics Market: End-use Movement Analysis
8.2 Hospitals
8.2.1 Hospitals Market, 2018 - 2030 (USD Million)
8.3 Diagnostic Laboratories
8.3.1 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
8.4 Physician Offices
8.4.1 Physician Offices Market, 2018 - 2030 (USD Million)
8.5 Other End-Users
8.5.1 Other End-Users Market, 2018 - 2030 (USD Million)
Chapter 9 Infectious Respiratory Disease Diagnostics Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)
9.1 Market Share Analysis
9.2 Regional Market Share Analysis, 2021 & 2030
9.3 Regional Market Snapshot
9.4 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
9.4.1 North America
9.4.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
9.4.1.2 U.S.
9.4.1.2.1 U.S. Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.1.3 Canada
9.4.1.3.1 Canada Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2 Europe
9.4.2.1 Europe Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.2 U.K.
9.4.2.2.1 U.K. Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.3 Germany
9.4.2.3.1 Germany Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.4 Spain
9.4.2.4.1 Spain Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.5 France
9.4.2.5.1 France Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.6 Italy
9.4.2.6.1 Italy Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.2.7 Russia
9.4.2.7.1 Russia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3 Asia Pacific
9.4.3.1 Asia Pacific Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.2 Japan
9.4.3.2.1 Japan Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.3 China
9.4.3.3.1 China Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.4 India
9.4.3.4.1 India Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.5 South Korea
9.4.3.5.1 South Korea Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.6 Australia
9.4.3.6.1 Australia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.3.7 Singapore
9.4.3.7.1 Singapore Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.4 Latin America
9.4.4.1 Latin America Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.4.2 Brazil
9.4.4.2.1 Brazil Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.4.3 Mexico
9.4.4.3.1 Mexico Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.4.4 Argentina
9.4.4.4.1 Argentina Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.5 MEA
9.4.5.1 MEA Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.5.2 South Africa
9.4.5.2.1 South Africa Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.5.3 Saudi Arabia
9.4.5.3.1 Saudi Arabia Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
9.4.5.4 UAE
9.4.5.4.1 UAE Infectious Respiratory Disease Diagnostics Market, 2018 - 2030 (USD Million)
Chapter 10 Infectious Respiratory Disease Diagnostics Market: Competitive Analysis
10.1 Recent Developments and Impact Analysis, by Key Market Participants
10.1.1 New Product Launches
10.1.2 Mergers And Acquisitions
10.1.3 Partnerships And Strategic Collaboration
10.1.4 Conferences And Campaigns
10.2 Company Categorization
10.2.1 Innovators
10.2.2 Market Leaders
10.2.3 Heat Map Analysis
10.3 Vendor Landscape
10.3.1 List Of Key Distributors And Channel Partners
10.3.2 Key Customers
10.4 Key Company Market Share Analysis, 2021
10.5 Public Companies
10.5.1 Company Market Position Analysis
10.5.2 Company Market Position Analysis
10.5.3 Competitive Dashboard Analysis
10.5.3.1 Market Differentiators
10.6 Private Companies
10.6.1 List Of Key Emerging Companies
10.6.2 Regional Network Map
10.7 Company Profiles
10.7.1 ABBOTT
10.7.1.1 Company overview
10.7.1.2 Financial performance
10.7.1.3 Product benchmarking
10.7.1.4 Strategic initiatives
10.7.2 THERMO FISHER SCIENTIFIC, INC.
10.7.2.1 Company overview
10.7.2.2 Financial performance
10.7.2.3 Product benchmarking
10.7.2.4 Strategic initiatives
10.7.3 KONINKLIJKE PHILIPS N.V.
10.7.3.1 Company overview
10.7.3.2 Financial performance
10.7.3.3 Product benchmarking
10.7.3.4 Strategic initiatives
10.7.4 F. HOFFMANN-LA ROCHE LTD
10.7.4.1 Company overview
10.7.4.2 Financial performance
10.7.4.3 Product benchmarking
10.7.4.4 Strategic initiatives
10.7.5 BIOMÉRIEUX SA
10.7.5.1 Company overview
10.7.5.2 Financial performance
10.7.5.3 Product benchmarking
10.7.5.4 Strategic initiatives
10.7.6 BIO-RAD LABORATORIES, INC.
10.7.6.1 Company overview
10.7.6.2 Financial performance
10.7.6.3 Product benchmarking
10.7.6.4 Strategic initiatives
10.7.7 QUIDEL CORPORATION
10.7.7.1 Company overview
10.7.7.2 Financial performance
10.7.7.3 Product benchmarking
10.7.7.4 Strategic initiatives
10.7.8 CEPHEID (DANAHER)
10.7.8.1 Company Overview
10.7.8.2 Financial Performance
10.7.8.3 Product Benchmarking
10.7.8.4 Strategic Initiatives
10.7.9 QIAGEN
10.7.9.1 Company Overview
10.7.9.2 Financial Performance
10.7.9.3 Product Benchmarking
10.7.9.4 Strategic Initiatives
10.7.10 SIEMENS HEALTHCARE GMBH
10.7.10.1 Company Overview
10.7.10.2 Financial Performance
10.7.10.3 Product Benchmarking
10.7.10.4 Strategic Initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート

Grand View Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21 10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る